三次元(3D)細胞培養の世界市場

Allied Market Researchが発行した調査報告書(AMR8040807)
◆英語タイトル:3D Cell Culture Market by Product Type [Scaffold-Based Platforms (Macro-Porous, Micro-Porous, Nano-Porous, and Solid Scaffolds), Scaffold-Free Platforms, Gels, Bioreactors, Microchips, and Services], Application (Cancer Research, Stem Cell Research, Drug Discovery, and Regenerative Medicine), and End User (Biotechnology & Pharmaceutical Companies, Contract Research Laboratories, and Academic Institutes) - Global Opportunity Analysis and Industry Forecast, 2014-2022
◆商品コード:AMR8040807
◆発行会社(リサーチ会社):Allied Market Research
◆発行日:2017年1月
◆ページ数:150
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:Medical Devices & Supplies
◆販売価格オプション(消費税別)
Single UserUSD4,999 ⇒換算¥539,892見積依頼/購入/質問フォーム
5 UserUSD6,229 ⇒換算¥672,732見積依頼/購入/質問フォーム
Enterprise UserUSD6,979 ⇒換算¥753,732見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAllied Market Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Cell culture refers to growth of cells in an artificially created, controlled environment, which is used to study the metabolism pathways in molecular and cellular biology. Various types of cell cultures include two-dimensional (2D) and three-dimensional (3D). 2D cell culture has multiple disadvantages such as they can neither provide adequate extracellular components nor appropriate in vivo environment. Moreover, there is lack of cell–cell and cell–matrix interactions, which are essential to study the functions, proliferation, and differentiation of a cell. 3D cell culture is an artificially created environment that facilitates interactions of cells with their surroundings in all three dimensions.
3D cell culture is a rapidly evolving technique in the field of research and technology. They are used to precisely observe and analyze the aspects of a cell such as morphology, differentiation, migration, and proliferation. These interactions assist to study the etiology of a disease, which boosts the growth of the market. In addition, 3D cultures can be used to reconstruct the physiology and anatomy of tissues. Moreover, they can be used to reconstruct in vivo-like conditions in a laboratory to conduct research on drug development and diseased models.

The global 3D cell culture market is estimated to reach $4,691 million by 2022 from $765 million in 2015, registering a CAGR of 29.4% from 2016 to 2022. The market growth is driven by rapidly expanding customer base, proactive government initiatives for the development of 3D cell cultures, and extensive R&D activities. The 3D cell culture technique has revolutionized various sectors such as tissue engineering and drug discovery for cancer, which further boosts the growth of the market. Moreover, collaborations between academic institutions, hospitals, and companies; rise in investments by major players; and high demand for organ transplantation have supplemented the market growth. However, high investments requirements and dearth of experienced & skilled professionals are the key factors that restrain the market growth.

The report segments the 3D cell culture market based on product type, application, end user, and geography. On the basis of product type, the market is categorized into scaffolds, scaffold-free platforms, gels, bioreactors, and microchips. Scaffold-based platforms are further classified into macro-porous, micro-porous, nano-porous, and solid scaffolds. Applications covered in the study include cancer research, stem cell research, drug discovery, and regenerative medicine. By end user, the market comprises biotechnology & pharmaceutical companies, contract research laboratories, and academic institutes. Geographically, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, Republic of South Africa, and rest of LAMEA).

KEY BENEFITS

This report entails a detailed quantitative analysis of the current market trends for the period of 2014–2022 to identify the prevailing opportunities in the market.
The market estimations provided in the report are based on comprehensive analysis of the key developments in the industry.
The global market is comprehensively analyzed with respect to product type, application, end user, and geography to assist in strategic business planning.
Recent developments and strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.
The key market players in the 3D cell culture market are profiled in this report along their growth strategies to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Product Type

Scaffold-Based Platforms
Macro-Porous Scaffolds
Micro-Porous Scaffolds
Nano-Porous Scaffolds
Solid Scaffolds
Scaffold-Free Platforms
Gels
Bioreactors
Microchips
Services

By Application

Cancer Research
Stem Cell Research
Drug Discovery
Regenerative Medicine

By End User

Biotechnology & Pharmaceutical Companies
Contract Research Laboratories
Academic Institutes

By Geography

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
Republic of South Africa
Rest of LAMEA

The key players profiled in this report include

3D Biotek, LLC
Advanced Biomatrix, Inc.
Becton, Dickinson and Company
Corning Incorporated
Kuraray Co., Ltd.
Lonza Group Ltd.
Merck & Co., Inc.
Synthecon, Incorporated
Thermo Fisher Scientific Inc.
VWR Corporation

Other players of the 3D cell culture market include (companies not profiled in the report):

Global Cell Solutions, Inc.
InSphero AG
Nanofiber Solutions
Tecan Trading AG

【レポートの目次】

Chapter: 1 INTRODUCTION

1.1. Report Description
1.2. Key Benefits
1.3. Key Market Segments
1.4. Research Methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. Market Definition And Scope
3.2. Key Findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PATENT ANALYSIS

3.3.1. Patent analysis, by year
3.3.2. Patent analysis, by country

3.4. TOP IMPACTING FACTORS
3.5. DRIVERS

3.5.1. Advantages of 3D culture techniques over 2D techniques
3.5.2. Augmented investments in R&D activities
3.5.3. Rise in prevalence rate of cancer
3.5.4. Increase in demand for organ transplantation

3.6. RESTRAINTS

3.6.1. Dearth of skilled professionals
3.6.2. Budget restriction for research-related activities

3.7. OPPORTUNITIES

3.7.1. Technological advancements

Chapter: 4 GLOBAL 3D CELL CULTURE MARKET, BY PRODUCT TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. SCAFFOLD-BASED PLATFORM

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Macro-porous Scaffold-based Platform
4.2.5. Micro-porous Scaffold-based Platform
4.2.6. Nano-porous Scaffold-based Platform
4.2.7. Solid Scaffolds Platform

4.3. SCAFFOLD-FREE PLATFORM

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast

4.4. GELS

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

4.5. BIOREACTORS

4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast

4.6. MICROCHIPS

4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast

4.7. SERVICES

4.7.1. Key market trends
4.7.2. Key growth factors and opportunities
4.7.3. Market size and forecast

Chapter: 5 GLOBAL 3D CELL CULTURE MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. CANCER RESEARCH

5.2.1. Market size and forecast

5.3. STEM CELL RESEARCH

5.3.1. Market size and forecast

5.4. DRUG DISCOVERY

5.4.1. Market size and forecast

5.5. REGENERATIVE MEDICINE

5.5.1. Market size and forecast

Chapter: 6 GLOBAL 3D CELL CULTURE MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES

6.2.1. Market size and forecast

6.3. CONTRACT RESEARCH LABORATORIES

6.3.1. Market size and forecast

6.4. ACADEMIC INSTITUTES

6.4.1. Market size and forecast

Chapter: 7 3D CELL CULTURE MARKET, BY GEOGRAPHY

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S.
7.2.5. Canada
7.2.6. Mexico

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany
7.3.5. France
7.3.6. UK
7.3.7. Rest of Europe

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. China
7.4.5. Japan
7.4.6. India
7.4.7. Australia
7.4.8. Rest of Asia-Pacific

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Brazil
7.5.5. Saudi Arabia
7.5.6. Republic of South Africa
7.5.7. Rest of LAMEA

Chapter: 8 COMPANY PROFILES

8.1. 3D BIOTEK LLC

8.1.1. Company overview
8.1.2. Key strategic moves and developments

8.2. ADVANCED BIOMATRIX, INC.

8.2.1. Company overview

8.3. BECTON, DICKINSON AND COMPANY

8.3.1. Company overview
8.3.2. Operating business segments
8.3.3. Business performance

8.4. CORNING INCORPORATED

8.4.1. Company overview
8.4.2. Operating business segments
8.4.3. Business performance
8.4.4. Key strategic moves and developments

8.5. KURARAY CO., LTD.

8.5.1. Company overview
8.5.2. Operating business segments
8.5.3. Business performance

8.6. LONZA GROUP LTD

8.6.1. Company overview
8.6.2. Operating business segments
8.6.3. Business performance
8.6.4. Key strategic moves and developments

8.7. MERCK & CO., INC.

8.7.1. Company overview
8.7.2. Operating business segments
8.7.3. Business performance
8.7.4. Key strategic moves and developments

8.8. SYNTHECON, INCORPORATED

8.8.1. Company overview

8.9. THERMO FISHER SCIENTIFIC INC.

8.9.1. Company overview
8.9.2. Operating business segments
8.9.3. Business performance
8.9.4. Key strategic moves and developments

8.10. VWR CORPORATION

8.10.1. Company overview
8.10.2. Business performance

TABLE 1. PATENTS REGISTERED/APPROVED, BY YEAR (2010-2016)
TABLE 2. PATENTS REGISTERED/APPROVED, BY COUNTRY (2010-2016)
TABLE 3. GLOBAL 3D CELL CULTURE MARKET, BY PRODUCT TYPE ($MILLION), 2014-2022
TABLE 4. 3D CELL CULTURE SCAFFOLD-BASED MARKET, BY REGION ($MILLION), 2014-2022
TABLE 5. 3D CELL CULTURE SCAFFOLD-BASED MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 6. 3D CELL CULTURE SCAFFOLD-FREE MARKET, BY REGION ($MILLION), 2014-2022
TABLE 7. 3D CELL CULTURE GELS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 8. 3D CELL CULTURE BIOREACTORS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 9. 3D CELL CULTURE MICROCHIPS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 10. 3D CELL CULTURE SERVICES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 11. GLOBAL 3D CELL CULTURE MARKET, BY APPLICATION ($MILLION), 2014-2022
TABLE 12. 3D CELL CULTURE CANCER MARKET, BY REGION ($MILLION), 2014-2022
TABLE 13. 3D CELL CULTURE STEM CELL RESEARCH MARKET, BY REGION ($MILLION), 2014-2022
TABLE 14. 3D CELL CULTURE DRUG DISCOVERY MARKET, BY REGION ($MILLION), 2014-2022
TABLE 15. 3D CELL CULTURE REGENERATIVE MARKET, BY REGION ($MILLION), 2014-2022
TABLE 16. GLOBAL 3D CELL CULTURE MARKET, BY END USER ($MILLION), 2014-2022
TABLE 17. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES 3D CELL CULTURE MARKET, BY REGION ($MILLION), 2014-2022
TABLE 18. CONTRACT RESEARCH LABORATORIES 3D CELL CULTURE MARKET, BY REGION ($MILLION), 2014-2022
TABLE 19. ACADEMIC INSTITUTES 3D CELL CULTURE MARKET, BY REGION ($MILLION), 2014-2022
TABLE 20. 3D CELL CULTURE MARKET, BY REGION ($MILLION), 2014-2022
TABLE 21. NORTH AMERICA 3D CELL CULTURE MARKET, BY PRODUCT TYPE ($MILLION), 2014-2022
TABLE 22. NORTH AMERICA 3D CELL CULTURE MARKET, BY APPLICATION ($MILLION), 2014-2022
TABLE 23. NORTH AMERICA 3D CELL CULTURE MARKET, BY END USER ($MILLION), 2014-2022
TABLE 24. NORTH AMERICA 3D CELL CULTURE MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 25. EUROPE 3D CELL CULTURE MARKET, BY PRODUCT TYPE ($MILLION), 2014-2022
TABLE 26. EUROPE 3D CELL CULTURE MARKET, BY APPLICATION ($MILLION), 2014-2022
TABLE 27. EUROPE 3D CELL CULTURE MARKET, BY END USER ($MILLION), 2014-2022
TABLE 28. EUROPE 3D CELL CULTURE MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 29. ASIA-PACIFIC 3D CELL CULTURE MARKET, BY PRODUCT TYPE ($MILLION), 2014-2022
TABLE 30. ASIA-PACIFIC 3D CELL CULTURE MARKET, BY APPLICATION ($MILLION), 2014-2022
TABLE 31. ASIA-PACIFIC 3D CELL CULTURE MARKET, BY END USER ($MILLION), 2014-2022
TABLE 32. ASIA-PACIFIC 3D CELL CULTURE MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 33. LAMEA 3D CELL CULTURE MARKET, BY PRODUCT TYPE ($MILLION), 2014-2022
TABLE 34. LAMEA 3D CELL CULTURE MARKET, BY APPLICATION ($MILLION), 2014-2022
TABLE 35. LAMEA 3D CELL CULTURE MARKET, BY END USER ($MILLION), 2014-2022
TABLE 36. LAMEA 3D CELL CULTURE MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 37. 3D BIOTEK: COMPANY SNAPSHOT
TABLE 38. ADVANCED BIOMATRIX: COMPANY SNAPSHOT
TABLE 39. BD: COMPANY SNAPSHOT
TABLE 40. BD: OPERATING SEGMENTS
TABLE 41. CORNING: COMPANY SNAPSHOT
TABLE 42. CORNING: OPERATING SEGMENTS
TABLE 43. KURARAY: COMPANY SNAPSHOT
TABLE 44. KURARAY: OPERATING SEGMENTS
TABLE 45. LONZA: COMPANY SNAPSHOT
TABLE 46. LONZA: OPERATING SEGMENTS
TABLE 47. MERCK: COMPANY SNAPSHOT
TABLE 48. MERCK: OPERATING SEGMENTS
TABLE 49. SYNTHECON: COMPANY SNAPSHOT
TABLE 50. THERMO FISHER: COMPANY SNAPSHOT
TABLE 51. THERMO FISHER: OPERATING SEGMENTS
TABLE 52. VWR: COMPANY SNAPSHOT

FIGURE 1. GLOBAL 3D CELL CULTURE MARKET SEGMENTATION
FIGURE 1. TOP INVESTMENT POCKETS: GLOBAL 3D CELL CULTURE MARKET, BY PRODUCT TYPE
FIGURE 2. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)
FIGURE 3. PATENTS REGISTERED/APPROVED, BY YEAR (2010-2016)
FIGURE 4. PATENTS REGISTERED/APPROVED, BY COUNTRY (2010-2016)
FIGURE 5. MACRO-POROUS SCAFFOLD-BASED MARKET ($MILLION), 2014-2022
FIGURE 6. MICRO-POROUS SCAFFOLD-BASED MARKET ($MILLION), 2014-2022
FIGURE 7. NANO-POROUS SCAFFOLD-BASED MARKET ($MILLION), 2014-2022
FIGURE 8. SOLID SCAFFOLDS MARKET ($MILLION), 2014-2022
FIGURE 9. 3D CELL CULTURE MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 10. U.S. 3D CELL CULTURE MARKET ($MILLION), 2014-2022
FIGURE 11. CANADA 3D CELL CULTURE MARKET ($MILLION), 2014-2022
FIGURE 12. MEXICO 3D CELL CULTURE MARKET ($MILLION), 2014-2022
FIGURE 13. GERMANY 3D CELL CULTURE MARKET ($MILLION), 2014-2022
FIGURE 14. FRANCE 3D CELL CULTURE MARKET ($MILLION), 2014-2022
FIGURE 15. UK 3D CELL CULTURE MARKET ($MILLION), 2014-2022
FIGURE 16. REST OF EUROPE 3D CELL CULTURE MARKET ($MILLION), 2014-2022
FIGURE 17. CHINA 3D CELL CULTURE MARKET ($MILLION), 2014-2022
FIGURE 18. JAPAN 3D CELL CULTURE MARKET ($MILLION), 2014-2022
FIGURE 19. INDIA 3D CELL CULTURE MARKET ($MILLION), 2014-2022
FIGURE 20. AUSTRALIA 3D CELL CULTURE MARKET ($MILLION), 2014-2022
FIGURE 21. REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET ($MILLION), 2014-2022
FIGURE 22. BRAZIL 3D CELL CULTURE MARKET ($MILLION), 2014-2022
FIGURE 23. SAUDI ARABIA 3D CELL CULTURE MARKET ($MILLION), 2014-2022
FIGURE 24. REPUBLIC OF SOUTH AFRICA 3D CELL CULTURE MARKET ($MILLION), 2014-2022
FIGURE 25. REST OF LAMEA 3D CELL CULTURE MARKET ($MILLION), 2014-2022
FIGURE 26. BD: NET SALES, 2013-2015 ($MILLION)
FIGURE 27. BD: NET SALES BY SEGMENT, 2015
FIGURE 28. BD: NET SALES BY GEOGRAPHY, 2015
FIGURE 29. CORNING: NET SALES, 2013-2015 ($MILLION)
FIGURE 30. CORNING: NET SALES BY SEGMENT, 2015
FIGURE 31. CORNING: NET SALES BY GEOGRAPHY, 2015
FIGURE 32. KURARAY: NET SALES, 2013-2015 ($MILLION)
FIGURE 33. KURARAY: NET SALES BY SEGMENT, 2015
FIGURE 34. KURARAY: NET SALES BY GEOGRAPHY, 2015
FIGURE 35. LONZA: NET SALES, 2013-2015 ($MILLION)
FIGURE 36. LONZA: NET SALES BY SEGMENT, 2015
FIGURE 37. LONZA: NET SALES BY GEOGRAPHY, 2015
FIGURE 38. MERCK: NET SALES, 2013-2015 ($MILLION)
FIGURE 39. MERCK: NET SALES BY SEGMENT, 2015
FIGURE 40. MERCK: NET SALES BY GEOGRAPHY, 2015
FIGURE 41. MERCK: NET SALES BY GEOGRAPHY, 2015 (%)
FIGURE 42. THERMO FISHER: NET SALES, 2013-2015 ($MILLION)
FIGURE 43. THERMO FISHER: NET SALES BY SEGMENT, 2015 (%)
FIGURE 44. THERMO FISHER: NET SALES BY GEOGRAPHY, 2015
FIGURE 45. VWR: NET SALES, 2013-2015 ($MILLION)
FIGURE 46. VWR: NET SALES BY GEOGRAPHY, 2015

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 三次元(3D)細胞培養の世界市場(3D Cell Culture Market by Product Type [Scaffold-Based Platforms (Macro-Porous, Micro-Porous, Nano-Porous, and Solid Scaffolds), Scaffold-Free Platforms, Gels, Bioreactors, Microchips, and Services], Application (Cancer Research, Stem Cell Research, Drug Discovery, and Regenerative Medicine), and End User (Biotechnology & Pharmaceutical Companies, Contract Research Laboratories, and Academic Institutes) - Global Opportunity Analysis and Industry Forecast, 2014-2022)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆